Digestive Diseases and Sciences

, Volume 48, Issue 6, pp 1035–1049 | Cite as

Inducible Nitric Oxide Synthase Inhibitors Ameliorate Hypermotility Observed After T. spiralis Infection in the Rat

  • D. Torrents
  • N. Prats
  • P. Vergara


Trichinella spiralis infection in rodents is a well-known model of intestinal inflammation associated with hypermotility and hypersecretion. Our aim was to use this experimental model to elucidate if iNOS was involved in the development of gastrointestinal hypermotility. Rats infected with Trichinella spiralis were treated for 4 days with the nitric oxide synthase inhibitors L-NAME or L-NIL. Treatment began either simultaneously with the infection or 3 days after infection when inflammation was already fully developed. In all cases, at day 10–12 after infection, anesthetized rats were prepared with strain gauges and electrodes in the small intestine to evaluate motor activity of the small intestine. In addition, histology and iNOS immunohistochemistry studies were performed. The results showed that both NOS inhibitors blocked iNOS expression in the intestine. None of the NOS inhibitors attenuated the inflammatory process. However, the preventive treatment with L-NIL reversed hypermotility. In contrast, the treatment with NOS inhibitors 3 days after infection was not so effective in reversing motor alterations. L-NAME, but not L-NIL, caused alterations on spontaneous motility. In conclusion, these results indicate that iNOS participates in the development of motor hypermotility in the gut.

cholecystokinin Crohn's disease irritable bowel syndrome intestinal inflammation nitric oxide 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Camilleri M: Management of the irritable bowel syndrome. Gastroenterology 120:652-658, 2001Google Scholar
  2. 2.
    Azpiroz F: Dimensions of gut dysfunction in irritable bowel syndrome: altered sensory function. Can J gastroenterol 13:12A-14A, 1999Google Scholar
  3. 3.
    Palmer JM, Weisbrodt NW, Castro GA: Trichinella spiralis: intestinal myoelectric activity during enteric infection in the rat. Exp Parasitol 57:132-141, 1984Google Scholar
  4. 4.
    Torrents D, Vergara P: In vivo changes in the intestinal reflexes and the response to CCK in the inflamed small intestine of the rat. Am J Physiol 279:G453-G451, 2000Google Scholar
  5. 5.
    Castro GA: Intestinal physiology of the parasitized host: integration, desintegration, and reconstruction of systems. Ann NY Acad Sci 664:369-379, 1992Google Scholar
  6. 6.
    Daniel EE, Haugh C, Woskowska Z, Cipris S, Jury J, Fox-Threlkeld: Role of nitric oxide-related inhibition in intestinal function: relation to vasoactive intestinal peptide. Am J Physiol 266:G31-G39, 1994Google Scholar
  7. 7.
    Rodriguez-Membrilla A, Martínez V, Jiménez M, Goñalons E, Vergara P: Is nitric oxide the final mediator regulating the migrating myoelectric complex cycle? Am J Physiol 268:G207-G214, 1995Google Scholar
  8. 8.
    Whittle BJ, Lopez-Belmonte J, Moncada S: Regulation of gastric mucosa integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol 99:607-611, 1990Google Scholar
  9. 9.
    Hoffman RA, Zhang G, Nussler NC, Gleixner SL, Ford HR, Simmon RL, Watkins SC: Constitutive expression of inducible nitric oxide synthase in the mouse ileal mucosa. Am J Physiol 272:G383-G392, 1997Google Scholar
  10. 10.
    Roberts PJ, Riley GP, Morgan K, Miller R, Hunter JO, Middleton S: The physiological expression of inducible nitric oxide synthase (iNOS) the human colon. J Clin Pathol 54:293-297, 2001Google Scholar
  11. 11.
    Vento P, Kiviluoto T, Jarvinen HJ, Soinila S: Changes in distribution of three isoforms of nitric oxide synthase in ulcerative colitis. Scand J Gastroenterol 36:180-189, 2001Google Scholar
  12. 12.
    Chen K, Hirota S, Wasa M, Okada A: Expression of NOSII and its role in experimental small bowel unceration in rats. Surgery 126:553-561, 1999Google Scholar
  13. 13.
    Kalff JC, Schraut WH, Billiar TR, Simmons RL, Bauer AJ: Role of inducible nitric oxide synthase in postoperative intestinal smooth muscle dysfunction in rodents. Gastroenterology 118:316-327, 2000Google Scholar
  14. 14.
    Bian K, Harari Y, Zhong M, Lai M, Castro G, Weisbrodt N, Murad F: Down-regulation of inducible-oxide synthase (NOS-2) during parasite-induced gut inflammation: a path to identify a selective NOS-2 inhibitor. Mol Pharmacol 59:939-947, 2001Google Scholar
  15. 15.
    Hutcheson IR, Whittle BJR, Boughton-Sith NK: Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 101:815-820, 1990Google Scholar
  16. 16.
    Miller MJS, Sadowska-Krowicka H, Chotinaruemol S, Kakkis JL, Clark DA: Amelioration of chronic ileitis by nitric oxide synthase inhibition. J Pharmacol Exp Ther 264:11-16, 1993Google Scholar
  17. 17.
    Hogaboam CM, Jacobson K, Collins SM, Blennerhassett MG: The selective beneficial effects of nitric oxide inhibition in the experimental colitis. Am J Physiol 268:G673-G684, 1995Google Scholar
  18. 18.
    Rachmilewitz D, Karmeli F, Okon E, Bursztyn M: Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut 37:247-255, 1995Google Scholar
  19. 19.
    Hogaboam CM, Collins SM, Blennerhassett MG: Effects of oral L-NAME during Trichinella spiralis infection in rats. Am J Physiol 271:G338-G346, 1996Google Scholar
  20. 20.
    Khan IA, Schwartzman JD, Matsuura T, Kasper LH: A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Proc Natl Acad Sci USA 94:13955-13960, 1997Google Scholar
  21. 21.
    Konturek PC, Brzozowski T, Sliwowski Z, Pajdo R, Stachura J, Hahn EG, Konturek SJ: Involvement of nitric oxide and prostaglandins in gastroprotection induced by bacterial lipopolysaccharide. Scand J Gastroenterol 33:691-700, 1998Google Scholar
  22. 22.
    Dikopoulos N, Nussler AK, Liptay S, Bachem M, Reinshagen M, Stiegler M, Schmid RM, Adler G, Weidenbach H: Inhibition of nitric oxide synthesis by aminoguanidine increases intestinal damage in the acute phase of rat TNB-colitis. Eur J Clin Invest 31:234-239, 2001Google Scholar
  23. 23.
    Castro GA, Fairbairn D: Carbohydrates and lipids in Trichinella spiralis larvae and their utilization in vitro. J Parasitol 55:51-58, 1969Google Scholar
  24. 24.
    Giralt M, Vergara V: Inhibition by CCK of ascending contraction elicited by mucosal stimulation in the duodenum of the rat. Neurogastroenterol Motil 12:173-180, 2000Google Scholar
  25. 25.
    Collins SM, Blennerhassett PA, Blennerhassett MG, Vermillion DL: Impaired acetylcholine release from the myenteric plexus of Trichinella-infected rats. Am J Physiol 257:G898-G903, 1989Google Scholar
  26. 26.
    Swain MG, Blennerhassett PA, Collins SM: Impaired sympathetic nerve function in the inflamed rat intestine. Gastroenterololgy 100:675-682, 1991Google Scholar
  27. 27.
    Mizuta Y, Isomoto H, Takahashi T: Impaired nitrergic innervation in rat colitis induced by dextran sulfate sodium. Gastroenterology 118:714-723, 2000Google Scholar
  28. 28.
    Stead RH: Nerve remodeling during intestinal inflammation. Ann NY Acad Sci 664:443-455, 1992Google Scholar
  29. 29.
    Giralt M, Vergara P: Both afferent and efferent nerves are implicated in the cholecystokinin motor actions in the small intestine of the rat. Regul Pept 81:73-80, 1999Google Scholar
  30. 30.
    Torrents D, Torres R, De Mora F, Vergara P: Antinerve Growth Factor treatment prevents intestinal dysmotility in Trichinella spiralis-infected rats. J Pharmacol Exp Ther 302:659-665, 2002Google Scholar
  31. 31.
    Tamura CS, Ritter RC: Intestinal capsaicin transiently attenuates suppression of sham feeding by oleate. Am J Physiol 267:R561-R568, 1992Google Scholar
  32. 32.
    Naliboff BD, Munakata J, Fullerton S, Gracely RH, Kodner A, Harraf F, Mayer EA: Evidence for two distinct perceptual alteration in irritable bowel syndrome. Gut 41:505-512, 1997Google Scholar
  33. 33.
    Harvey RF, Read AE: Effect of cholecystokinin on colonic motility and symptoms in patients whith the irritable-bowel syndrome. Lancet 7793:1-3, 1973Google Scholar
  34. 34.
    Allescher HD, Sattler D, Piller C, Schusdziarra V, Classen M: Ascending neural pathways in the rat ileum in vitro: effect of capsaicin and involvement of nitric oxide. Eur J Pharmacol 217:153-162, 1992Google Scholar
  35. 35.
    Costa M, Brookes S, Waterman S, Mayo R: Enteric neuronal circuitry and transmitters controlling intestinal motor function. In Advances in the Innervation of the Gastrointestinal Tract. GE Holle, JD Wood (eds). Amsterdam, Elsevier Science, 1992, pp 115-121Google Scholar
  36. 36.
    Marzio L, Blennerhassett P, Chiverton S, Vermillion DL, Larger J, Collins SM: Altered smooth muscle function in worm-free gut regions of Trichinella-infected rats. Am J Physiol 259:G306-G313, 1990Google Scholar
  37. 37.
    Tanovic A, Fernandez E, Jimenez M: Functional responses of smooth muscle from free intestinal segments of Trichinella spiralis infected rats. Neurogastroenterol Motil 11:294, 1999 (abstract)Google Scholar
  38. 38.
    Thomas S, Ramachandran A, Patra S, Vidyasagar S, Balasubramanian KA: Nitric oxide protects the intestine from the damage induced by laparotomy and gut manipulation. J Surg Res 99:25-32, 2001Google Scholar
  39. 39.
    Lawrence CE, Paterson JCM, Wei XQ, Liew FY, Garside P, Kennedy MW: Nitric oxide mediates intestinal pathology but not immune expulsion during Trichinella spiralis infection in mice. J Immunol 164:4229-4234, 2000Google Scholar

Copyright information

© Plenum Publishing Corporation 2003

Authors and Affiliations

  • D. Torrents
    • 1
  • N. Prats
    • 2
  • P. Vergara
    • 1
  1. 1.Department of Cell Biology, Physiology and ImmunologyUniversitat Autònoma de BarcelonaSpain
  2. 2.Departament of Animal Health and Animal AnatomyUniversitat Autònoma de BarcelonaSpain

Personalised recommendations